RHEA JEFFERS: Open Payments
NPI 1528429602 · ENGLEWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,000 in 327 payments from 19 companies in 2025. Trend: 2023 $6,544 · 2024 $5,828 · 2025 $7,000
Food & beverage: $6,996Education: $4
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 34 | $1,134 |
| Axsome Therapeutics, Inc. | 34 | $915 |
| Otsuka America Pharmaceutical, Inc. | 52 | $835 |
| E.R. Squibb & Sons, L.L.C. | 28 | $787 |
| ABBVIE INC. | 51 | $636 |
| Janssen Pharmaceuticals, Inc | 14 | $539 |
| Alkermes, Inc. | 19 | $495 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $455 |
| Teva Pharmaceuticals USA, Inc. | 17 | $397 |
| Lundbeck LLC | 29 | $362 |
Products named: REXULTI, Auvelity, COBENFY, FANAPT, VRAYLAR, HETLIOZ, CAPLYTA, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
